A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples